24 |
Direct Thrombin Inhibitors for PCI Pharmacology: Role of Bivalirudin in High Risk PCI |
Charles A. Simonton |
Sep. 14. 07 |
23 |
Bivalirudin on Trial: Rationale and Status of ISAR-REACT 3 and 4 |
Adnan Kastrati |
Sep. 14. 07 |
22 |
Genous Endothelial Progenitor Cell Capture Technology |
Michael Kutryk |
Jun. 01. 07 |
21 |
VH Experience in Real World: Asan Medical Center |
Seung-Jung Park |
Feb. 15. 07 |
20 |
Surrogate Markers of CHD & Statins |
Wolfgang Koenig |
Nov. 24. 06 |
19 |
The Cholesterol Balance: The Advanced Approach to Dyslipidemia Management |
Peter Jan Lansberg |
Nov. 24. 06 |
18 |
Application of 'Bone Marrow Mononuclear Cells' for Pts with MI; Lessons from BOOST Program |
Kai C. Wollert |
Nov. 24. 06 |
17 |
Medical Environment Post-PCI |
Jean Fajadet |
Oct. 27. 06 |
16 |
Final Results From the ORBIT Clinical Trials |
Ron Waksman |
Aug. 11. 06 |
15 |
Systemic Therapy: Pharmacologic Approach or Cell/Gene Therapy |
Alan C. Yeung |
Jun. 16. 06 |